|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1080938487 |
003 |
OCoLC |
005 |
20231120010335.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
190104s2019 enk ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d UKMGB
|d OPELS
|d OCLCF
|d YDX
|d DKU
|d OCLCO
|d STF
|d OCLCO
|d OCLCA
|d S2H
|d OCLCO
|d LVT
|d UX1
|d VT2
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
015 |
|
|
|a GBB913028
|2 bnb
|
015 |
|
|
|a GBB913812
|2 bnb
|
016 |
7 |
|
|a 019207304
|2 Uk
|
019 |
|
|
|a 1081264702
|a 1229518574
|a 1235822251
|
020 |
|
|
|a 9780128137529
|q (electronic bk.)
|
020 |
|
|
|a 0128137525
|q (electronic bk.)
|
020 |
|
|
|z 9780128137512
|
020 |
|
|
|z 0128137517
|
035 |
|
|
|a (OCoLC)1080938487
|z (OCoLC)1081264702
|z (OCoLC)1229518574
|z (OCoLC)1235822251
|
050 |
|
4 |
|a QP572.O74
|
060 |
|
4 |
|a 2019 C-608
|
060 |
|
4 |
|a WL 104
|
072 |
|
7 |
|a MED
|x 075000
|2 bisacsh
|
072 |
|
7 |
|a SCI
|x 036000
|2 bisacsh
|
072 |
|
7 |
|a PSAN
|2 bicssc
|
082 |
0 |
4 |
|a 612.405
|2 23
|
245 |
0 |
4 |
|a The orexin/hypocretin system :
|b functional roles and therapeutic potential /
|c [edited by] Joshua A. Burk, Jim R. Fadel.
|
250 |
|
|
|a First edition.
|
264 |
|
1 |
|a London, United Kingdom :
|b Academic Press,
|c [2019]
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
|
|
|a Online resource; title from PDF title page (EBSCO, viewed January 10, 2019).
|
520 |
|
|
|a The Orexins/Hypocretins System: Functional Roles and Therapeutic Potential summarizes research on both the physiological functioning of orexins, their impact on homeostatic processes, and related disorders. The book encompasses the effects on appetite, sleep, substance abuse, cognition, and anxiety. Additionally, it examines new therapeutic approaches utilizing orexins, including utilization of orexin receptors for drug development. It is essential reading for neuroscience researchers interested in brain-behavior relationships, as well as psychiatrists, endocrinologists and pharmacologists.
|
650 |
|
0 |
|a Orexins.
|
650 |
|
0 |
|a Narcolepsy.
|
650 |
|
2 |
|a Orexins
|0 (DNLM)D000068797
|
650 |
|
2 |
|a Narcolepsy
|0 (DNLM)D009290
|
650 |
|
6 |
|a Orexines.
|0 (CaQQLa)000265869
|
650 |
|
6 |
|a Narcolepsie.
|0 (CaQQLa)201-0006361
|
650 |
|
7 |
|a MEDICAL
|x Physiology.
|2 bisacsh
|
650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Human Anatomy & Physiology.
|2 bisacsh
|
650 |
|
7 |
|a Narcolepsy
|2 fast
|0 (OCoLC)fst01032764
|
650 |
|
7 |
|a Orexins
|2 fast
|0 (OCoLC)fst01736359
|
700 |
1 |
|
|a Burk, Joshua A.,
|e editor.
|
700 |
1 |
|
|a Fadel, Jim R.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Orexin/hypocretin system.
|b First edition.
|d London, United Kingdom : Academic Press, [2019]
|z 0128137517
|z 9780128137512
|w (OCoLC)1047779806
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128137512
|z Texto completo
|